Company: EVGN
Filing Date: 2025-03-27
Form Type: 20-F
Source: 0001178913-25-001092
Chunk: 242

Company: Evogene Ltd.
Filing Date: 2025-03-27
Form: 20-F
Item: Item 9
Chunk 242
---
 agreement Casterra received, an order totaling $9.1 million in June 2023.
In June 2023, Casterra received an additional order totaling approximately $2.2 million for the supply of castor seeds.

On June 25, 2024, Casterra announced the receipt of an additional
purchase order valued at approximately $440 thousand.

During 2023, Casterra supplied approximately 90 tons of seeds.
During 2024, Casterra supplied approximately 215 tons of seeds. Commencing in January 2025 and until the date of this Annual Report, Casterra
supplied additional approximately 250 tons of seeds. This reflects solving the bottleneck in seed production Casterra previously faced,
that caused a delay in the delivery schedule and consequent price adjustments.

Casterra is currently negotiating with ENI to supply additional
approximately 234 tons of seeds, in lieu of expired previous orders from 2023.

Information on that transaction is set forth in this Annual Report
under “ Item 5. Operating and Financial Review and Prospects - B. Liquidity and Capital Resources - Casterra Agreement with
ENI” and is incorporated by reference herein.

Lavie Bio Licensing Agreement for Bio-Fungicides
with Corteva Agriscience

On July 14, 2023, Lavie Bio entered into a licensing agreement
with Corteva Inc. This agreement grants Corteva perpetual, exclusive rights (subject to reaching certain commercial milestones) to
further develop and commercialize the lead bio-fungicide candidates targeting fruit rots and powdery mildew, which were discovered and
developed by Lavie Bio.

In November 2024 Lavie Bio received notice of termination of this
agreement. Pursuant to the terms of the agreement, Lavie Bio received an initial payment of $ 5.0 million from Corteva, which will not
be repaid to Corteva because of the termination. Lavie Bio has regained all rights to the licensed technology and the lead bio-fungicide
candidates.

Information on that transaction is set forth in this Annual Report
under “ Item 5. Operating and Financial Review and Prospects - B. Liquidity and Capital Resources - Lavie Bio Licensing
Agreement for Bio-Fungicides with Corteva Agriscience” and is incorporated by reference herein.

102

Indemnification Agreements

We have entered into indemnification agreements with our office
holders. Information on the indemnification agreements may be found in this Annual Report under